West Pharmaceutical
226 hedge funds and large institutions have $2.81B invested in West Pharmaceutical in 2014 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 72 increasing their positions, 95 reducing their positions, and 30 closing their positions.
43% more call options, than puts
Call options by funds: $529K | Put options by funds: $370K
0.22% less ownership
Funds ownership: 90.42% → 90.2% (-0.22%)
7% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 30
2% less funds holding
Funds holding: 230 → 226 (-4)
9% less capital invested
Capital invested by funds: $3.1B → $2.81B (-$289M)
24% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 95
50% less funds holding in top 10
Funds holding in top 10: 10 → 5 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$54.6M |
| 2 |
JP Morgan Chase
New York
|
+$27.1M |
| 3 |
Renaissance Technologies
New York
|
+$23.5M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$9.61M |
| 5 |
Millennium Management
New York
|
+$8.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIA
Denver Investment Advisors
Denver,
Colorado
|
-$18.1M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$16M |
| 3 |
Bank of New York Mellon
New York
|
-$13.2M |
| 4 |
SAM
Silvercrest Asset Management
New York
|
-$12.7M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$8.57M |
WST Hedge Fund Activity: Q1 2014 in Review
226 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q1 2014, worth a combined $2.81B — down 9.3% from $3.1B a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of WST and 28 opened new positions — a net loss of 2 holders — while 95 trimmed existing stakes and 72 added.
The largest buyer was State Street, adding an estimated $54.6M. The largest seller was Denver Investment Advisors, cutting an estimated $18.1M.
- 226 institutional investors held West Pharmaceutical (WST) as of Q1 2014, down from 230 in Q4 2013.
- Funds reported $2.81B of West Pharmaceutical stock for Q1 2014, down 9.3% quarter-over-quarter.
- 28 funds opened new West Pharmaceutical positions in Q1 2014 and 30 closed out, a net change of -2 holders.
- The largest West Pharmaceutical buyer in Q1 2014 was State Street, an estimated $54.6M added.
- The largest West Pharmaceutical seller in Q1 2014 was Denver Investment Advisors, an estimated $18.1M sold.
Based on aggregated 13F filings for Q1 2014.